Stay updated with breaking news from Tarsus pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tarsus Pharmaceuticals, Inc. (TARS) Thursday announced positive results from the Phase 2a Carpo trial evaluating TP-05 or lotilaner, an investigational oral therapeutic for the prevention of Lyme disease. ....
Bank of America favorable on SMID-cap biotechs into 2024 seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Tarsus Pharmaceuticals, Inc. (TARS) announced the FDA approved XDEMVY 0.25% for the treatment of Demodex blepharitis. XDEMVY is the first and only FDA approved treatment to directly target Demodex mites, the company noted. ....